| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 18.901 | 29.565 | 35.318 | 57.767 |
| Total Income - EUR | - | - | - | - | - | - | 18.901 | 29.565 | 35.318 | 57.767 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 529 | 8.907 | 9.495 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 18.901 | 29.036 | 26.411 | 48.272 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 18.334 | 28.313 | 26.056 | 47.694 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Le Matt Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 469 | 137 | 757 |
| Current Assets | - | - | - | - | - | - | 18.921 | 37.435 | 38.116 | 48.025 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 7.379 | 2.028 | 36.911 | 30.730 |
| Cash | - | - | - | - | - | - | 11.543 | 35.407 | 1.205 | 17.295 |
| Shareholders Funds | - | - | - | - | - | - | 18.354 | 36.051 | 26.080 | 47.718 |
| Social Capital | - | - | - | - | - | - | 20 | 20 | 20 | 20 |
| Debts | - | - | - | - | - | - | 567 | 1.853 | 12.173 | 1.063 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Le Matt Bio S.r.l.